I can show you where the selling pressure by Aspir
Post# of 72446
(Total Views: 464)
Posted On: 03/09/2018 2:37:46 PM
I can show you where the selling pressure by Aspire came from, but I doubt Alan can show you where the selling pressure by naked shorts came from.
"During the period from July 1, 2017 to September 5, 2017, the Company generated proceeds of approximately $2.1 million under the 2015 Agreement from the sale of approximately 2.6 million shares of its common stock. During the period from September 6, 2017 to December 31, 2017, the Company generated proceeds of approximately $4.4 million under the 2017 Agreement from the sale of approximately 6.6 million shares of its common stock."
"From January 1, 2018 to February 7, 2018, the Company has generated additional proceeds of approximately $0.6 million under the Common Stock Purchase Agreement with Aspire Capital from the sale of approximately 0.9 million shares of its common stock."
https://www.sec.gov/Archives/edgar/data/13552...ix_10q.htm
So that's a total of ~10.1 million shares from July 1, 2017 to February 7, 2018. Since Aspire's MO isn't to hold long-term (no Schedule 13G filed), the average daily shares sold during that period were:
10,100,000 shares / 31 weeks / (5 days / week) = 65,161 shares / day
As you can see, ~65K shares per day created a tremendous selling pressure for a stock which averaged ~200K. Market manipulation or naked shorting wasn't the main reason for the current SP IMO. When a partnership is announced and Aspire isn't needed, IPIX will really take off.
"During the period from July 1, 2017 to September 5, 2017, the Company generated proceeds of approximately $2.1 million under the 2015 Agreement from the sale of approximately 2.6 million shares of its common stock. During the period from September 6, 2017 to December 31, 2017, the Company generated proceeds of approximately $4.4 million under the 2017 Agreement from the sale of approximately 6.6 million shares of its common stock."
"From January 1, 2018 to February 7, 2018, the Company has generated additional proceeds of approximately $0.6 million under the Common Stock Purchase Agreement with Aspire Capital from the sale of approximately 0.9 million shares of its common stock."
https://www.sec.gov/Archives/edgar/data/13552...ix_10q.htm
So that's a total of ~10.1 million shares from July 1, 2017 to February 7, 2018. Since Aspire's MO isn't to hold long-term (no Schedule 13G filed), the average daily shares sold during that period were:
10,100,000 shares / 31 weeks / (5 days / week) = 65,161 shares / day
As you can see, ~65K shares per day created a tremendous selling pressure for a stock which averaged ~200K. Market manipulation or naked shorting wasn't the main reason for the current SP IMO. When a partnership is announced and Aspire isn't needed, IPIX will really take off.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
